Standard precautions: what is meant and what is not

E.T. Curran^*
*NHS National Services Scotland, Health Protection Scotland, UK
Journal of Hospital Infection (2015) 90, 10-11
No abstract.
サマリー原文（英語）はこちら
監訳者コメント：
英国ではカルバペネム分解酵素産生菌の感染対策にからみ、標準予防策とは何かの記載について、WHO と CDC、スコットランド地方の保健当局ならびに英国のエビデンスに基づく感染予防ガイドライン（epic3 プロジェクト）との間で食い違いがあり混乱を招いていると指摘、概念の統一性と今後の進歩に期待を寄せている。

Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections

Healthcare-associated infections and antimicrobial use in long-term care facilities (HALT3): an overview of the Italian situation

Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis

H. Namikawa*, W. Imoto, K. Yamada, Y. Tochino, Y. Kaneko, H. Kakeya, T. Shuto
*Osaka Metropolitan University, Japan

Journal of Hospital Infection (2023) 142, 88-95

Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile

Efficacy of five ‘sporicidal’ surface disinfectants against Clostridioides difficile spores in suspension tests and 4-field tests

S.Gemein*, R. Andrich, B. Christiansen, M. Decius, M. Exner, B. Hunsinger, E. Imenova, G. Kampf, T. Koburger-Janssen, K. Konrat, H. Martiny, M. Meckel, N.T. Mutters, F-A. Pitten, S. Schulz, I. Schwebke, J. Gebel
*University Hospital Bonn, Germany

Journal of Hospital Infection (2022) 122, 140-147